InvestorsHub Logo
Followers 4
Posts 1139
Boards Moderated 0
Alias Born 04/27/2006

Re: None

Thursday, 07/23/2015 8:35:26 PM

Thursday, July 23, 2015 8:35:26 PM

Post# of 8521
The only detail on Herceptin SC came as response to a question. Launched in 44-45 countries with a little over 30% conversion.

MabThera SC is 1 1/2 year behind Herceptin.

Pretty much a nothing report as far as HALO and not worth the hours of reading/listening. If not for the 1 question, Roche offered nothing about Herceptin or MabThera SC.

Never argue with a fool, for after awhile, it becomes difficult to determine which is the fool.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News